Pear Therapeutics Receives Safer Technologies Program (STeP) Designation from FDA for Product Candidate to Treat Acute and Chronic Pain
BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called…
How The Robot Revolution Affects the Manufacturing Business
Maybe Theaters Should Do More Than Cry Over Spilled Milk
Beyond the Button: Designing Intuitive Software for Content Creation Workflows
Understanding AI’s Beneficiaries
Company Profile: Assimilate Inc. 
